First off, it announced today that it plans to acquire Nutrisense — a CGM startup that targets nondiabetics. Stelo, its over-the-counter CGM, is also getting an FDA-cleared redesign that includes “pattern recognition, proactive AI coaching, and personalized weekly and daily summaries.” Hopefully, these moves help ease the data fatigue I experienced in my yearlong experiment with CGMs as a nondiabetic.